TIME has released its inaugural "World's Top HealthTech Companies 2025" list, in partnership with Statista. The ranking highlights 400 companies from over 25 countries across six market segments. The companies were evaluated based on a combination of financial performance, reputation analysis, and online engagement.

The current healthcare innovation economy presents a compelling and complex paradox for investors. The broader US healthcare venture capital fundraising landscape has experienced a significant decline, with the total for the first half of 2025 at just $3 Billion, a steep drop from the previous year. This puts the sector on track for its worst fundraising year in over a decade. This market contraction is largely attributed to economic and political uncertainty, coupled with a

Nelson Advisors Partner Lloyd Price will Chair the panel discussing the European HealthTech Investment Landscape, covering key questions such as: Which countries or regions in Europe are emerging as HealthTech hubs? Beyond the traditional powerhouses like the UK, Germany, and France, are there new centers of innovation, particularly in Central and Eastern Europe (CEE)? How are macroeconomic factors impacting the market? How are rising interest rates and inflation affecting d

European HealthTech Market Analysis - September 2025: Transition from Fragmented Point Solutions into Critical Healthcare Infrastructure....

The field of vagus nerve neuromodulation (VNN) is undergoing a profound transformation, moving beyond its established applications to emerge as a cornerstone of bioelectronic medicine. While vagus nerve stimulation (VNS) has long been a recognised treatment for refractory epilepsy and treatment-resistant depression, recent technological breakthroughs and landmark clinical trial results are expanding its therapeutic reach into a wide array of chronic inflammatory, neurological

Nelson Advisors LLP, a UK-based firm, is explicitly and exclusively focused on providing mergers and acquisitions (M&A) advisory services within the healthcare technology sector across the United Kingdom, Europe, and North America. The firm’s core value proposition is rooted in a distinctive "practitioner-led" approach. This model is a direct function of the synergistic partnership between its two co-founders, whose professional backgrounds combine extensive corporate finance

The European HealthTech and MedTech sectors are undergoing a profound transformation, moving from a fragmented, early-stage ecosystem to a mature, consolidating landscape ripe for sophisticated private equity (PE) strategies. This report serves as a strategic blueprint for PE firms aiming to capitalise on this evolution. The analysis reveals that the European digital health market has emerged as a global leader in funding growth, propelled by a strategic pivot towards fewer,

The European digital health market is at a pivotal inflection point, with the musculoskeletal (MSK) sector emerging as a primary frontier for innovation and investment. This market is not merely growing; it is undergoing a fundamental transformation, driven by an aging demographic, the increasing prevalence of chronic conditions, and a critical shift towards data-enabled, value-based care. The European Digital MSK market is projected to reach a revenue of US$3.28 Billion by 2

Ambient Voice Technology in the UK: Research Series by Nelson Advisors. The Accelerating UK NHS Ambient Voice Technology Market: Dynamics, Key Players, and Strategic Imperatives report. Ambient Voice Technology and the NHS 10 Year Plan: Strategy, Future Applications, Key Suppliers, Funding and Regulatory Landscape. NHS Ambient Voice Technology Market Heats Up in the UK - key players include TORTUS AI, Heidi Health, ClinicLetter.ai, Scribetech, Suki, Nuance, Tandem.

Lloyd Price, partner at HealthTech M&A firm Nelson Advisors, said the London results were encouraging on that front also. He said: “One of the biggest takeaways from the GOSH trial is the high level of public comfort and consent rate to using ambient voice technologies. To generate all of the productivity and efficiency gains, patients/carers/parents need to agree to being recorded and transcribed. Without high levels of public trust, technology solutions will struggle to be

The relationship between medical technology (MedTech) and defence technology has historically been characterised by an ad hoc, one-directional flow of innovation, often described as a "spin-out" effect where military research unexpectedly finds civilian applications. However, a contemporary analysis reveals a more complex, mutually beneficial, and increasingly institutionalized symbiosis. This interdependence is no longer a matter of serendipitous discovery but a deliberate,

The landscape of business education in Europe is undergoing a fundamental transformation, with HealthTech emerging as a critical nexus of innovation, capital, and leadership. This analysis posits that the traditional metrics of institutional prestige, while important, no longer provide a complete picture for prospective students and industry partners. A more granular, and ultimately more valuable, evaluation necessitates an in-depth examination of a school's specific HealthTe

The landscape of obesity and cardiometabolic disease management is on the cusp of a profound transformation, driven by the emergence of a new generation of oral therapies. For years, the remarkable efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss and glycemic control has been inextricably linked to injectable formulations, creating a market dominated by medications like semaglutide (Wegovy) and tirzepatide (Zepbound). However, the imminent approva

This report provides a detailed analysis of Nelson Advisors, a highly specialised mergers and acquisitions (M&A), partnerships and investment advisory firm. The firm is exclusively dedicated to the dynamic European medical technology (MedTech) sector, with an extended reach into the UK and North America. The analysis reveals that the firm's primary competitive advantage is rooted in its unique "Founders for Founders" approach, which is underpinned by the direct entrepreneuria

The global gut health market is in the midst of a profound transformation, evolving from a niche category focused on basic digestive relief into a mainstream, data-driven wellness sector. Projected to grow from $38.8 Billion in 2021 to $90.2 Billion by 2031 with a compound annual growth rate (CAGR) of 8.8%, this market is poised for robust expansion. This growth is not merely a quantitative increase but a qualitative shift, driven by a foundational change in consumer mindset